Korngold and Jonathan Sprent
نویسندگان
چکیده
Unprimed T cells transferred to heavily irradiated H-2-compatible mice cause a high incidence of lethal graft-vs.-host disease (GVHD)a in certain strain combinations (1-3). GVHD in this setting is a consequence of mature post-thymic donor T cells responding to the multiple minor histocompatibility antigen (minor HA) differences of the host. With the combination of CBA and B10.BR (both H-2~), doses of as few as 106 CBA T cells regularly kill close to 100% of irradiated B10.BR mice. Recent studies with this strain combination demonstrated that T cells eliciting lethal GVHD to minor HA are subject to H-2-restriction (4). To examine this question, CBA T cells were reeirculated through irradiated mice of the B10 H-2 congenic lines and then tested for their capacity to kill B10.BR mice. When CBA T cells were filtered from blood to lymph for 1 d through irradiated B10.BR or H-2-semisyngeneic (CBA × B10)F1 mice, negative selection occurred, i.e., the filtered T cells failed to kill B10.BR mice on further transfer. Selection was not apparent, however, when CBA T cells were filtered through totally H-2-different irradiated mice, e.g., B10 (H-2°), B10.D2 (H-2a), or B 10.S (H-if). Selection thus depended upon a sharing of H-2 determinants between the donor and host. These findings raised a number of questions, including: (a) What is the relationship between T cells causing GVHD to minor HA and minor HA-specific cytotoxic lymphocytes (CTL)? (b) Do GVHD-indueing T cells, like CTL, comprise discrete subgroups of H-2Kand H-2D-restricted cells? (c) Are H-2I-restricted cells involved in GVHD to minor HA? (d) What cells present minor HA to T cells during negative selection? (e) Is antigen processing involved during negative selection? This paper attempts to provide answers to these questions.
منابع مشابه
Crossing barriers in transplantation
In 1978, Jonathan Sprent and Robert Korngold proved that graft-versus-host disease (GVHD) is caused by donor T cells that attack the host's non-MHC antigens. T cell depletion of donor grafts has since become a staple of transplantation strategies to combat leukemia and other inherited blood disorders.
متن کامل